Ownership history in SCHULHOFF & CO INC · 9 quarters on record
This page tracks every 13F SEC filing in which SCHULHOFF & CO INC reported a position in PYXIS ONCOLOGY INC (PYXS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 275,000 | — | 0% | 0.26% | $610K | $2.22 |
| 2025 Q2 | ADDED | 275,000 | +153,000 | +125.4% | 0.13% | $302K | $1.10 |
| 2025 Q1 | UNCHANGED | 122,000 | — | 0% | 0.05% | $120K | $0.98 |
| 2024 Q4 | UNCHANGED | 122,000 | — | 0% | 0.07% | $190K | $1.56 |
| 2024 Q3 | ADDED | 122,000 | +80,000 | +190.5% | 0.19% | $448K | $3.67 |
| 2024 Q2 | ADDED | 42,000 | +20,000 | +90.9% | 0.06% | $139K | $3.31 |
| 2024 Q1 | UNCHANGED | 22,000 | — | 0% | 0.04% | $94K | $4.26 |
| 2023 Q4 | UNCHANGED | 22,000 | — | 0% | 0.02% | $40K | $1.80 |
| 2023 Q3 | INITIATED | 22,000 | — | — | 0.02% | $44K | — |
As of 2025 Q4 — sorted by position size